IL-23 is involved in the occurrence of an inflammation on the level of the synovial membrane [45], and the application of anti-IL23 therapies enjoyed real success in psoriatic arthritis, determining a better quality of patients’ lives, up to complete remission in some patients [46]. Here, IL37 is linked to psoriatic arthritis.